Brief: Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD

Phathom Pharmaceuticals

06/12/2023 13:16

Dec 6 (Reuters) - Phathom Pharmaceuticals Inc  PHAT.O :
    * PHATHOM PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE FOR
FILING OF
VOQUEZNA® (VONOPRAZAN) TABLETS NEW DRUG APPLICATION FOR THE
TREATMENT OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GERD
    * PHATHOM PHARMACEUTICALS- FDA ASSIGNED APPLICATION STANDARD
10-MONTH REVIEW WITH PRESCRIPTION DRUG USER FEE ACT  TARGET
ACTION DATE OF JULY 19, 2024

Source text for Eikon:  ID:nGNX2XkNFj 
Further company coverage:  PHAT.O 

 ((Reuters.Briefs@thomsonreuters.com;))